or
forgot password
  • cancer clinical trials in san francisco, CA

  • BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Kaiser Permanente-San Francisco

    Trial Locations
    Kaiser Permanente-San Francisco
    Kaiser Permanente-Hayward
    Breast Cancer
    Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
    California Pacific Medical Center

    Trial Locations
    California Pacific Medical Center
    University of California at San Francisco
    Aspergillosis, Invasive Fungal Infections
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Kaiser Permanente-San Francisco
    San Francisco, California 94115
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Neuroblastoma
    Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
    University of California San Francisco Medical Center-Mount Zion

    Trial Locations
    University of California San Francisco Medical Center-Mount Zion
    University of California San Francisco Medical Center-Parnassus
    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Tumor
    Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
    ARIAD Investigational Site #075
    San Francisco, California 94143
    Chronic Myelogenous Leukemia, Hematologic Malignancies
    S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Kaiser Permanente Medical Center - San Francisco Geary Campus

    Trial Locations
    Kaiser Permanente Medical Center - San Francisco Geary Campus
    California Pacific Medical Center - California Campus
    Lung Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    California Pacific Medical Center
    San Francisco, California 94115
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Symptom Management After Breast Cancer Surgery
    UCSF Comprehensive Cancer Center
    San Francisco, California 94115
    Neuropathic Pain, Postmastectomy Pain
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    California Pacific Medical Center - California Campus
    San Francisco, California 94118
    Colorectal Cancer
    Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Retinoblastoma
    Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Aids-related Malignancies, Lymphoma, Precancerous Condition, Sarcoma
    Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Sexual Dysfunction, Physiological
    Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
    University of California, San Francisco
    San Francisco, California 94143
    Glioblastoma Multiforme
    MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Nonmalignant Neoplasm, Prostate Cancer
    Improving Cancer Pain Management Through Self-Care
    UCSF Helen Diller Comprehensive Cancer Center

    Trial Locations
    UCSF Helen Diller Comprehensive Cancer Center
    San Francisco Veterans Affairs Medical Center
    Cancer, Pain
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
    University of California- San Francisco
    San Francisco, California 94143
    Multiple Myeloma, Renal Insufficiency
    Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
    California Pacific Medical Center - California Campus
    San Francisco, California 94118
    Colorectal Cancer
    Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    San Francisco Oncology Associates
    San Francisco, California 94115
    Renal Cell Carcinoma
    A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
    University of California, San Francisco
    San Francisco, California 94143
    Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma, Malignant Astrocytoma NOS
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma
    University of California, San Francisco
    San Francisco, California 94143
    Malignant Pleural Mesothelioma
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Kaiser Permanente-San Francisco
    San Francisco, California 94115
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    A Phase II Study of AS1411 in Renal Cell Carcinoma
    University of California San Francisco
    San Francisco, California 941104206
    Metastatic Renal Cell Carcinoma
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Lung Cancer
    Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Breast Cancer, Chemotherapeutic Agent Toxicity, Palmar-plantar Erythrodysesthesia
    Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Breast Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Prostate Active Surveillance Study
    University of California, San Francisco
    San Francisco, California 94143
    Prostatic Neoplasms
    Exhaled Breath Biomarkers in Finding Ovarian Epithelial Cancer in Patients With Newly Diagnosed Ovarian Epithelial Cancer, Polycystic Ovarian Syndrome, or Endometriosis and in Healthy Participants
    UCSF Helen Diller Family Comprehensive Cancer Center

    Trial Locations
    UCSF Helen Diller Family Comprehensive Cancer Center
    California Pacific Medical Center - California Campus
    Ovarian Cancer
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    San Francisco Oncology Associates

    Trial Locations
    San Francisco Oncology Associates
    Northern California Melanoma Center, St. Mary's Medical Center
    Melanoma
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    California Pacific Medical Center - California Campus
    San Francisco, California 94118
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    California Pacific Medical Center

    Trial Locations
    California Pacific Medical Center
    Kaiser Permanente-San Francisco
    University of California San Francisco Medical Center-Mount Zion
    San Francisco General Hospital
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    California Pacific Medical Center

    Trial Locations
    California Pacific Medical Center
    University of California San Francisco Medical Center-Mount Zion
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
    Site Reference ID/Investigator# 13861
    San Francisco, California 94115
    Melanoma, Metastatic Melanoma, Skin Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Kaiser Permanente Medical Center - San Francisco Geary Campus

    Trial Locations
    Kaiser Permanente Medical Center - San Francisco Geary Campus
    UCSF Helen Diller Family Comprehensive Cancer Center
    Endometrial Cancer, Fatigue, Neurotoxicity
    Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
    Kaiser Permanente Medical Center - San Francisco Geary Campus

    Trial Locations
    Kaiser Permanente Medical Center - San Francisco Geary Campus
    UCSF Helen Diller Family Comprehensive Cancer Center
    Lymphoma